Technology

Welcome to the big leagues, Netflix

Published

2 months ago

December 6, 2025

Warner Bros. has an infamous history of being bought by other companies and then quickly ending up back on the market after its new owners realize how difficult it is to capitalize on a legacy production studio’s assets. Those challenges are part of what doomed WB’s mergers with AOL and AT&T, who bought the studio in attempts to reinvent themselves. But WB’s latest acquisition deal — this time with Netflix for $83 billion — feels like it has the potential to turn out differently because of how much of a major player within the entertainment industry the streamer has become. It also signals just how far Netflix has come: in less than two decades the streamer has gone from tech upstart to subsuming one of the most storied studios in Hollywood.

Assuming that the deal receives regulatory approval, Netflix will soon own the entirety of Warner Bros.’ (but not Discovery Global’s) assets, which includes HBO / HBO Max, DC Studios, and the legacy studio’s television and film production arms. This would make Netflix the corporate home to many more of the world’s biggest entertainment franchises, like Game of Thrones and Harry Potter, and give the streamer a much larger operational footprint as a proper studio. Discovery Global — which retains ownership of networks including CNN, the Discovery Channel, and TLC — is set to become an independent corporate entity by Q3 in 2026.

This strategic bifurcation and sale of assets was obviously WBD’s desired outcome when the company first announced earlier this year that it planned to split Warner Bros. and Discovery back into two units. Back then, CEO David Zaslav had not yet announced that the company was open to acquisition offers. But you could glean as much from looking at the way that WBD was struggling to turn a profit with its linear cable networks.

Even though WBD managed to pay down a substantial portion of the $55 billion debt it inherited when Discovery bought WarnerMedia, the merged company’s flagging cable TV assets were a major factor in it receiving a significantly downgraded credit score earlier this year. That debt — a holdover from AOL’s disastrous merger with Time Warner — loomed over WBD for the entirety of Zaslav’s tenure as CEO.

A blend of money problems, misguided rebrands, and multiple rounds of layoffs left WBD in a very precarious position that made selling itself off to the highest bidder one of its only viable options to appease shareholders. Those challenges might also be difficult for Netflix to deal with, but this situation feels like it could shake out very differently for a handful of key reasons.

Unlike previous mergers where Warner Bros. was gobbled up by traditional tech giants and telecoms, the new deal is coming at a time when Netflix has long since established itself as a Hollywood power player. In addition to acquiring IP that goes on to become hits, the streamer has built out a robust production infrastructure to spin up wholly original projects of its own. And with many of the platform’s subscriber-generating projects like Stranger Things and Squid Game coming to an end, it’s easy to understand why it wanted to scoop up Warner Bros.’ sizable library of films and series. Netflix doesn’t have the strongest track record of building its own franchises — remember Rebel Moon? — and that’s exactly what it’s getting with WB.

Though Netflix feels like a better acquisition partner compared to Warner Bros.’ previous owners, this is still a consolidation and these kinds of mergers always come with casualties. And it is likely that we will soon start hearing about layoffs as Netflix begins dealing with internal redundancies created by its absorption of Warner Bros.’ employees and operations. But what is much less clear is how the newly merged studio will go about releasing its new projects.

In 2021 during the covid-19 pandemic’s height, WBD’s decision to debut movies on HBO Max as opposed to theaters prompted directors like Christopher Nolan to denounce the company for becoming “the worst streaming service.” Though box office numbers still haven’t returned to pre-pandemic levels, theaters have reopened, and breakout hits like Warner Bros.’ A Minecraft Movie and Superman features have made it clear that there is a demand to see movies on the big screen. Netflix has experimented with very limited theatrical releases that transparently read as plays to qualify its movies for major industry awards. But it has still primarily been a streaming company in the years since it got out of the DVD game.

Unlike MGM, which was on the decline when Amazon bought it, Warner Bros. has had a very strong track record with its recent theatrical releases. Netflix has said that it “expects” to keep putting Warner Bros.’ movies in theaters, but co-CEO Ted Sarandos has signaled that the company is thinking about shortening its theatrical windows in order to “meet the audience where they are quicker.”

“I’d say right now, you should count on everything that is planned on going to the theater through Warner Bros. will continue to go to the theaters through Warner Bros. and Netflix movies will take the same strides they have,” Sarandos said this week in a call with industry analysts.

Netflix has also made abundantly clear that it is open to cutting production costs by using generative AI. The company has not mandated that its collaborators use the technology as part of their production workflows, but it is easy to imagine gen AI becoming a bigger part of the studio now that it has taken on all of the projects Warner Bros. has in development.

The more glaring concern to come out of the new merger is the way that this could impact competition between the major studios and streaming platforms. Netflix has effectively replaced Warner Bros. as one of the Big Five, which will likely change the entertainment industry’s power dynamics. But streaming customers will probably feel these shifts more directly as Netflix and its competitors settle into a new status quo.

Netflix’s prices could go up yet again under the auspice that the service has become more premium with Warner Bros.’ offerings. It’s still not clear how Netflix will handle the HBO / Max brands long term. The company has said that it thinks “HBO and HBO Max also provide a compelling, complementary offering for consumers,” but it would not be surprising to see those brands ultimately going the way of Hulu, which has been turned into a section within Disney Plus.

It has been years since Netflix was a rowdy upstart fighting to be taken seriously. But even though the company has already cemented itself as the world’s biggest TV / movie streamer, this new deal will take it to a different level of prominence. The Netflix / WBD merger will undoubtedly result in changes — some of them bad — that reverberate through the entire entertainment landscape.

But as tumultuous as things will likely feel in the immediate future, it doesn’t seem likely that Netflix will end up trying to sell off Warner Bros. in a couple of years. Acquisitions of this scale aren’t the company’s usual MO, but it has been bullish about wanting Warner Bros. since the studio went on sale. If the deal goes through, Netflix is undoubtedly in the big leagues — now it has to prove it belongs.

Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.

Charles Pulliam-Moore

Related Topics:analysis Business Entertainment film Netflix Report streaming tv-shows

Click to comment

Technology

One year in, Big Tech has out-maneuvered MAGA populists

Published

28 minutes ago

January 21, 2026

Press Room

One year in, Big Tech has out-maneuvered MAGA populists

Welcome to Regulator, a newsletter for Verge subscribers about the technology and the tech bros upending American politics and the Trump administration. If you’re not a subscriber yet, and you’re interested in Silicon Valley’s adventures in sausage-making, you should do so here! It’s Q1! Surely the corporate budget will allow for it.

Precisely one year ago, Steve Bannon, the powerful, populist MAGA podcaster, was thrilled at the sight of the Big Tech CEOs swarming around Donald Trump. In the days before his inauguration, the major players were visiting Mar-a-Lago, signing checks, even showing up to sit quietly behind him during his second inauguration. For years, Bannon told ABC’s Jonathan Karl in an interview, Big Tech had undermined Trump: Jeff Bezos’ Washington Post had reported on him critically, for instance, while Meta and Alphabet’s subsidiaries had purportedly silenced his online presence. Now, Bannon said, they were “supplicants” to Trump, who’d hired MAGA regulators ready to tear apart those companies at any given moment. “Most people in our movement look at this as President Trump broke the oligarchs,” he bragged.

Even smaller pivots from firm MAGA positions in favor of the tech industry, and the response from said base, are telling. Last November, Trump sparked outrage from the right by defending the existence of H1-B visas for high-skilled foreign tech workers, going so far as to say that US workers lacked “certain talents” that prevented Big Tech from hiring domestically. Although Trump ended up radically overhauling the immigration lottery system in a more nativist favor, the continued existence of the H1-B visa program itself sparked a massive rift within the MAGAsphere: how could Trump let in any foreign workers, much less imply that they were better than American workers? What sort of “America First” was that?

For decades, even as a businessman, Trump’s had one consistent organizational principle: people and factions must constantly fight each other for his attention and favor. It happened all the time during Trump’s first term, when New York financiers, the Republican establishment, the career officials, Trump’s children, and the proto-MAGA wing were all fighting each other inside the West Wing. But by the time Trump returned to the campaign trail in 2024, the New Yorkers were exhausted and went home, the Republican establishment had caved to Trump, and the career officials were all about to be purged. MAGA populism had won, and they believed, to paraphrase Trump, that they would win so much that they would become tired of winning. It’s not like the populists haven’t claimed territory in Trump’s second administration. The Department of Justice is conducting lawfare against Trump’s critics, the Department of Homeland Security has given ICE a broadly terrifying mandate, and the Department of Defense (sorry, War) kidnapped a foreign head of state for the LOLs.

But honestly, I would not have expected a year ago, as I watched the tech CEOs applaud Trump in the Rotunda, that these “supplicants” would eventually sway Trump to their ways. I’m not sure how the next year looks for internal drama coming out of the White House. I will say, however, that it is very, very telling that Bannon, who once bragged that there was a plan in place for Trump to run for an unconstitutional third term, is reportedly eyeing a presidential run himself.

Well, in the sense of the Senate being on a one-week recess, during which I will be following the drama of Coinbase derailing the CLARITY Act over interest rates, before the Senate Banking Committee reconvenes. To my great regret, I am not at Davos, where CEO Brian Armstrong is and where most of the negotiations seem to be happening. So if you are in some private Swiss meeting with other tech overlords and have some insight into whether there will be an actual market structure bill passed in the upcoming year, please email me at tina@theverge.com, or over Signal at tina_nguyen.19.

Technology

FDA clears first at-home brain device for depression

Published

58 minutes ago

January 21, 2026

Press Room

FDA clears first at-home brain device for depression

NEWYou can now listen to Fox News articles!

For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home.

The approval comes from the U.S. Food and Drug Administration and marks a major shift in how mental health conditions may be treated. The newly approved device is called FL-100, and it comes from Flow Neuroscience.

It is designed for adults 18 and older with moderate to severe major depressive disorder. Clinicians can prescribe it as a stand-alone treatment or alongside antidepressants and therapy. This decision matters because depression affects more than 20 million adults in the U.S. Roughly one-third do not get enough relief from medication or stop taking it due to side effects.

Sign up for my FREE CyberGuy Report
Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide – free when you join my CYBERGUY.COM newsletter.

SIMPLE DAILY HABIT MAY HELP EASE DEPRESSION MORE THAN MEDICATION, RESEARCHERS SAY

Flow Neuroscience has gotten approval from the U.S. Food and Drug Administration for its FL-100 prescription brain-stimulation device. (Flow Neuroscience)

How the Flow FL-100 works

The FL-100 uses transcranial direct current stimulation, often shortened to tDCS. This technology delivers a gentle electrical current to the prefrontal cortex, a region of the brain tied to mood regulation and stress response. In many people with depression, activity in this area is reduced. By stimulating it, the device aims to restore healthier brain signaling over time. The system looks like a lightweight headset and pairs with a mobile app. Patients use it at home for about 30 minutes per day while clinicians monitor progress remotely.

The clinical results behind the approval

The FDA based its decision on a randomized controlled trial that evaluated home use under remote supervision. Participants who received active stimulation showed meaningful improvement on clinician-rated and self-reported depression scales. After 10 weeks of treatment, patients experienced an average symptom improvement of 58% compared to a control group. Many users reported noticeable changes within the first three weeks. The study was published in the journal Nature Medicine, adding credibility to the findings. Side effects were generally mild and short-term. Reported issues included skin irritation, redness, headaches, and brief stinging sensations at the electrode sites.

The FDA has approved the first prescription brain-stimulation device for at-home treatment of depression in the U.S., marking a major shift in mental healthcare. (hoto by ISSAM AHMED/AFP via Getty Images)

A growing shift toward tech-based mental health care

Flow’s device has already been used by more than 55,000 people across Europe, the U.K., Switzerland and Hong Kong. In the U.K., it is prescribed within parts of the public health system. Company leaders say the U.S. approval opens the door for broader access to non-drug treatment options. The momentum is not isolated. In 2025, researchers at UCLA Health developed another experimental brain-stimulation approach, signaling rapid growth in this field. Together, these advances suggest that at-home neuromodulation may soon become a standard part of depression care rather than a fringe option.

When will the device be available

Flow expects the FL-100 to be available to U.S. patients in the second quarter of 2026. A prescription will be required, and the companion app will be available on iOS and Android. The company also plans to explore additional uses for its platform, including sleep disorders, addiction, and traumatic brain injury.

10 HEALTH TECH PRODUCTS STEALING THE SPOTLIGHT AT CES 2026

Flow Neuroscience’s FL-100 headset delivers mild electrical stimulation to the brain and can be prescribed for home use under medical supervision. (Flow Neuroscience)

What to know before trying Flow

Flow is FDA approved for adults 18 and older with moderate to severe major depressive disorder, and it requires a prescription from a licensed healthcare provider. Doctors can recommend it on its own or alongside medication or therapy. The headset is non-invasive and designed for home use, but it is not meant for emergency situations or people considered treatment resistant. It also does not replace crisis care or immediate mental health support. Most users wear the headset for about 30 minutes per session. Mild tingling, warmth, skin irritation or headaches can happen, especially early on. These effects are usually short-lived and monitored by a clinician through the companion app.

Flow pairs with a mobile app that guides treatment and supports remote clinical oversight. Your provider sets the treatment plan, and the device follows prescribed settings to ensure safe use. Pricing and insurance coverage may vary once the device becomes available in the U.S. Some patients may access Flow through clinics, research programs, or as it becomes more widely adopted in routine depression care. The bottom line is simple. Flow adds another evidence-based option, not a cure and not a one-size-fits-all solution. For people who have struggled to find relief, having another clinically proven choice can matter a lot.

What this means to you

If you or someone you care about struggles with depression, this approval expands the range of real treatment options. It offers a non-drug path that can be used at home under medical guidance. For patients who have not responded well to medication or who experience unwanted side effects, this could provide another way forward. It also reflects a broader trend toward personalized, tech-enabled mental healthcare.

Take my quiz: How safe is your online security?

Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right and what needs improvement. Take my Quiz here: Cyberguy.com.

ELON MUSK SHARES PLAN TO MASS-PRODUCE BRAIN IMPLANTS FOR PARALYSIS, NEUROLOGICAL DISEASE

The newly approved device targets adults with moderate to severe depression and can be used alongside medication or therapy. (Photo by Sarah Silbiger/Getty Images)

Kurt’s key takeaways

This FDA approval feels like a real turning point. For years, brain stimulation for depression stayed locked inside clinics. Now it can happen at home with a doctor still guiding the process. That matters for people who have tried medications, dealt with side effects or felt stuck with limited options. This device will not be the right answer for everyone, but it gives patients and doctors one more proven tool to work with. And for many people living with depression, having another option could make all the difference.

If a doctor could prescribe a brain-stimulation headset instead of another pill, would you be open to trying it? Let us know by writing to us at Cyberguy.com.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Kurt “CyberGuy” Knutsson is an award-winning tech journalist who has a deep love of technology, gear and gadgets that make life better with his contributions for Fox News & FOX Business beginning mornings on “FOX & Friends.” Got a tech question? Get Kurt’s free CyberGuy Newsletter, share your voice, a story idea or comment at CyberGuy.com.

Technology

Google has finally killed the Stadia Bluetooth tool — but this person rescued it

Published

12 hours ago

January 20, 2026

Press Room

Google has finally killed the Stadia Bluetooth tool — but this person rescued it

Christopher Klay, who previously developed the Stadia Enhanced browser extension, is one of many who saved a copy of the tool to a personal GitHub page. What’s more, they’re hosting a working copy of that Google website right here to make it even easier.